Item 2. Unregistered Sales of Equity Securities
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table presents information with respect to purchases of common stock of the Company made during the three months ended March 28, 2025 by the Company or any “affiliated purchaser” of the Company as defined in Rule 10b-18(a)(3) under the Exchange Act:
Period Total Number of Shares Purchased 1
Average
Price Paid
Per Share Total Number of
Shares Purchased as Part of the Publicly
Announced Plan 2
Maximum Number
of Shares That May
Yet Be Purchased
Under the Publicly
Announced Plan
January 1, 2025 through January 24, 2025 1,665,513 $ 61.73 1,665,266 74,684,713
January 25, 2025 through February 21, 2025 3,045,474 66.80 1,766,420 72,918,293
February 22, 2025 through March 28, 2025 911,298 70.80 860,259 72,058,034
Total 5,622,285 $ 65.95 4,291,945
1 The total number of shares purchased includes: (1) shares purchased, if any, pursuant to the 2019 Plan described in footnote 2 below and (2) shares surrendered, if any, to the Company to pay the exercise price and/or to satisfy tax withholding obligations in connection with so-called stock swap exercises of employee stock options and/or the vesting of restricted stock issued to employees.
2 In February 2019, the Company publicly announced that our Board of Directors had authorized a plan (“2019 Plan”) for the Company to purchase up to 150 million shares of our common stock. This column discloses the number of shares purchased, if any, pursuant to the 2019 Plan during the indicated time periods (including shares purchased pursuant to the terms of preset trading plans meeting the requirements of Rule 10b5-1 under the Exchange Act).
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.